SCHEMBL2305166

SCHEMBL2305166

CS(=O)(=O)OC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1204323 0.73 USP2 (0.41)
SCHEMBL1193790 0.73 ALDH1A1 (0.33)
Methyl Carbamate SCHEMBL28068168 0.71 CA14 (0.40)
SCHEMBL4742771 0.71
SCHEMBL1947040 0.71
SCHEMBL7692952 0.71
SCHEMBL577100 0.71
SCHEMBL21816739 0.71
SCHEMBL27483727 0.71
SCHEMBL8705575 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117897386-A Benzopyran derivatives and uses thereof 斯帕克生物制药有限公司 2024-04-16 CN claimed
CN-101801935-B Uracil or thymine derivatives for the treatment of hepatitis C ABBOTT LAB 2014-12-03 CN claimed
CN-1044117-C Inhibitors of HIV protease useful for the treatment of aids LILLY CO ELI (US) 1999-07-14 CN claimed
CN-1094399-A Inhibitors of HIV protease as the treatment AIDS LILLY CO ELI (US) 1994-11-02 CN claimed
CN-113195441-B Androgen receptor modulators and methods of use thereof 埃萨制药股份有限公司 2024-07-12 CN disclosed
CN-118005640-A GCN2 inhibitors and uses thereof 默克专利股份有限公司 2024-05-10 CN disclosed
CN-117897386-A Benzopyran derivatives and uses thereof 斯帕克生物制药有限公司 2024-04-16 CN disclosed
CN-114380825-B Substituted pyrazole condensed ring derivative and preparation method and application thereof 北京志健金瑞生物医药科技有限公司 2024-02-13 CN disclosed
CN-111918651-B GCN2 inhibitors and uses thereof 默克专利股份有限公司 2024-01-30 CN disclosed
CN-116997547-A Granulin precursor modulators and methods of use thereof 阿库达医疗公司 2023-11-03 CN disclosed
CN-114369097-B Heteroaromatic AhR inhibitors 山东轩竹医药科技有限公司 2023-07-14 CN disclosed
CN-113490670-B Nitrogen-containing polycyclic condensed ring compound, pharmaceutical composition, preparation method and application thereof 北京志健金瑞生物医药科技有限公司 2023-06-02 CN disclosed
CN-1688527-A Fused benzene derivatives and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2005-10-26 CN disclosed
CN-1665809-A Azaindoles AVENTIS PHARMA LTD (GB) 2005-09-07 CN disclosed
EP-0732338-B1 2,2-Difluoro-3-carbamoyl ribose sulfonate compounds and process for the preparation of beta nucleosides LILLY CO ELI (US) 2002-05-15 EP disclosed
CN-1340050-A Heterocyclic benzenesulphonamide compounds as bradykinine antagonists FOURNIER IND & SANTE (FR) 2002-03-13 CN disclosed
CN-1044117-C Inhibitors of HIV protease useful for the treatment of aids LILLY CO ELI (US) 1999-07-14 CN disclosed
EP-0732338-A1 2,2-Difluoro-3-carbamoyl ribose sulfonate compounds and process for the preparation of beta nucleosides ELI LILLY AND COMPANY (US) 1996-09-18 EP disclosed
US-5521294-A 2,2-difluoro-3-carbamoyl ribose sulfonate compounds and process for the preparation of beta nucleosides ELI LILLY AND COMPANY (US) 1996-05-28 US disclosed
CN-1094399-A Inhibitors of HIV protease as the treatment AIDS LILLY CO ELI (US) 1994-11-02 CN disclosed